Atlas Trials

Phase I Biomarker Study (BMS-936558)

Clinical trial NCT01358721 · COMPLETED

Trial details

NCT number
NCT01358721
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2011-09-23
Primary completion
2014-12-01
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.